Magnesium and Affective Disorders

@article{Murck2002MagnesiumAA,
  title={Magnesium and Affective Disorders},
  author={Harald Murck},
  journal={Nutritional Neuroscience},
  year={2002},
  volume={5},
  pages={375 - 389}
}
  • H. Murck
  • Published 2002
  • Chemistry, Medicine
  • Nutritional Neuroscience
Abstract There are several findings on the action of magnesium ions supporting their possible therapeutic potential in affective disorders. Examinations of the sleep-electroencephalogram (EEG) and of endocrine systems point to the involvement of the limbic-hypothalamus-pituitary-adrenocortical axis as magnesium affects all elements of this system. Magnesium has the property to suppress hippocampal kindling, to reduce the release of adrenocorticotrophic hormone (ACTH) and to affect… Expand
Magnesium in depression.
TLDR
Pre-clinical and clinical studies confirmed the initial observations as well as demonstrated the beneficial safety profile of magnesium supplementation, and magnesium preparations seem to be a valuable addition to the pharmacological armamentarium for management of depression. Expand
Ketamine, magnesium and major depression--from pharmacology to pathophysiology and back.
  • H. Murck
  • Psychology, Medicine
  • Journal of psychiatric research
  • 2013
TLDR
Overall, any discussion of the glutamatergic system in affective disorders should consider the role of Mg(2+), and screening for compounds to increase neuronal M g(2+) concentration could be a promising instrument to identify new classes of antidepressants. Expand
Anxiolytic and antidepressive effects of magnesium in rats and their effect on general behavioural parameters.
Magnesium (Mg) is an essential element that catalyses more than 300 enzyme systems. Its effects on the central nervous system are exhibited through the blocking of activity of N-methyl D-aspartatExpand
Features of Central Neurotransmission in Animals in Conditions of Dietary Magnesium Deficiency and After Its Correction
TLDR
Dietary magnesium deficiency led to impairment of neurotransmission in central serotoninergic, M-cholinergic, and noradrenergic structures and administration of magnesium salts reversed these changes. Expand
Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims.
TLDR
Findings indicate that alterations in the zinc, magnesium andNMDA receptor complex in the hippocampus are potentially involved in the pathophysiology of suicide-related disorders (depression), which may lead to functional NMDA receptor hyperactivity. Expand
The Role of Magnesium in Neurological Disorders
TLDR
Overall, the mechanistic attributes of magnesium in neurological diseases connote the macromineral as a potential target for neurological disease prevention and treatment. Expand
Acth-induced model of depression resistant to tricyclic antidepressants: Neuroendocrine and behavioral changes and influence of long-term magnesium administration
TLDR
The findings provide further insights into the possible pathways implicated in the behavioral modulation effects of Mg, as well as its central and peripheral effects in ACTH‐induced TRD model, and suggest involvement of MG in central and periphery turnover of monoamines. Expand
Cocaine Use Disorders and Serum Magnesium Profile
TLDR
Cocaine addicts showed higher total plasma magnesium levels than opiate addicts and normal controls, even though they remained in the normal range, in the first study evaluating the magnesium level in cocaine addicts. Expand
[Magnesium deficiency and stress: Issues of their relationship, diagnostic tests, and approaches to therapy].
TLDR
The authors have developed and tested a simple rapid MD assessment test and a stress resistance self-rating test that will help to screen stress resistance and MD in outpatient settings. Expand
The Effect of Magnesium Deficiency on Neurological Disorders: A Narrative Review Article
TLDR
The role of Mg in neurological disorders is summarized to illustrate the symptoms caused by Mg-deficiency and the possible underlying mechanisms and a brief review of the recent literature is made. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 231 REFERENCES
The Glutamate Antagonist Riluzole and Its Effects upon Basal and Stress-Induced Activity of the Human Hypothalamus-Pituitary- Adrenocortical System in Elderly Subjects
TLDR
The antiglutamatergic drug riluzole did not have any effects upon HPA system activity under baseline and cognitive-stress-induced conditions in elderly subjects, but a trend for dampening the endocrine response to physical stress emerged. Expand
Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression.
TLDR
Hypofrontality and hyperactivity of the HPA-axis reinforce each other's actions in the development of the signs and symptoms of depression. Expand
Actions of lithium on the cyclic AMP signalling system in various regions of the brain--possible relations to its psychotropic actions. A study on the adenylate cyclase in rat cerebral cortex, corpus striatum and hippocampus.
  • A. Mørk
  • Chemistry, Medicine
  • Pharmacology & toxicology
  • 1993
TLDR
The present work aimed at investigating the mechanisms by which lithium in vitro and after chronic treatment (ex vivo) affects adenylate cyclase activities in various regions of the rat brain. Expand
Antidepressant mechanisms: functional and molecular correlates of excitatory amino acid neurotransmission
TLDR
This review will document current evidence for the involvement of excitatory amino acid neurotransmission in the pathophysiology of the affective disorders. Expand
The Corticosteroid Receptor Hypothesis of Depression
  • F. Holsboer
  • Biology, Medicine
  • Neuropsychopharmacology
  • 2000
TLDR
Mouse genetics, allowing for selective inactivation of genes relevant for HPA regulation and molecular pharmacology, dissecting the intracellular cascade of CR signaling, are the most promising future research fields, suited for identifying genes predisposing to depression. Expand
Mg2+ reduces ACTH secretion and enhances spindle power without changing delta power during sleep in men – possible therapeutic implications
TLDR
The findings are consistent with the assumption that Mg2+ has GABAA-agonistic or NMDA-antagonistic effects on sleep and nocturnal hormonal secretion and hence may be useful in controlling depressive symptoms and seizures. Expand
Brain and CSF magnesium concentrations during magnesium deficit in animals and humans: neurological symptoms.
  • M. Morris
  • Chemistry, Medicine
  • Magnesium research
  • 1992
Magnesium is an essential cofactor for many enzymatic reactions, especially those involved in energy metabolism. Deficits of magnesium are prevalent due to inadequate intake or malabsorption and dueExpand
Stimulation of adrenocorticotropin but not prolactin and catecholamine release by N-methyl-aspartic acid.
TLDR
The data indicate that NMA and NMDA administered in low doses trigger ACTH release without induction of a nonspecific stress response. Expand
The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.
  • F. Holsboer
  • Psychology, Medicine
  • Journal of psychiatric research
  • 1999
TLDR
Patients with clinical conditions that are causally related to HPA hyperactivity may profit from treatment with a CRH1 receptor antagonist, as the animals were less anxious than wild-type mice when experimentally stressed. Expand
The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences.
  • P. Gold, G. Chrousos
  • Psychology, Medicine
  • Proceedings of the Association of American Physicians
  • 1999
The cardinal clinical manifestations of major depression with melancholic features include sustained anxiety and dread for the future as well as evidence of physiological hyperarousal (e.g.,Expand
...
1
2
3
4
5
...